Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › North Carolina
Pag-aaral pangklinika para sa Chronic Inflammatory Demyelinating Polyradiculoneuropathy sa North Carolina
6 pag-aaral para sa Chronic Inflammatory Demyelinating Polyradiculoneuropathy ang naghahanap ng mga kalahok sa mga site sa North Carolina.
Opisyal na teksto ng pag-aaral (English)
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1635, Chapel Hill
- Site Number - 1610, Charlotte
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07032662Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- The Neurological Institute, PA, Charlotte
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05327114A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Raleigh Neurology Associates- Site Number : 8400043, Raleigh
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06290141Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
- PPD Virtual, Wilmington
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT07264426A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- University of North Carolina (UNC), Chapel Hill
- Duke University Hospital, Durham
- Raleigh Neurology Associates, Raleigh
- at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT06747351A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
- Wake Forest University - School of Medicine - Central, Winston-Salem
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 21, 2025 · NCT06538064Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.